2017
DOI: 10.1002/cpdd.343
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics and Safety of DW1029M, a Botanical Drug for the Treatment of Diabetic Nephropathy, Following Single Doses in Healthy Subjects

Abstract: DW1029M is a botanical extract of Morus albalinne root bark and Puerariae radix that is used for the treatment of diabetic nephropathy. This study evaluated the safety and pharmacokinetics of DW1029M following its administration in healthy Korean subjects. We conducted a randomized, open-label, single-dose, crossover phase 1 clinical study. During each period, subjects received 300, 600, or 1200 mg oral doses of DW1029M. Plasma concentrations of puerarin, daidzin, and daidzein were analyzed using a liquid chro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 30 publications
(44 reference statements)
0
3
0
Order By: Relevance
“…The silkworm midgut is the central tissue for nutrient absorption; furthermore, it serves as a barrier to prevent exogenous substances from entering the cells. Mulberry leaves contain polyphenols such as quercetin, apigenin, resveratrol, daidzein, and genistein [16][17][18][19][20], all of which have biological activity. For example, quercetin is used as an antioxidant to reduce the immunosuppressive effects of hyperglycemic sera in patients with type 2 diabetes [21].…”
Section: Plos Onementioning
confidence: 99%
“…The silkworm midgut is the central tissue for nutrient absorption; furthermore, it serves as a barrier to prevent exogenous substances from entering the cells. Mulberry leaves contain polyphenols such as quercetin, apigenin, resveratrol, daidzein, and genistein [16][17][18][19][20], all of which have biological activity. For example, quercetin is used as an antioxidant to reduce the immunosuppressive effects of hyperglycemic sera in patients with type 2 diabetes [21].…”
Section: Plos Onementioning
confidence: 99%
“…Diabetic nephropathy (DN), a chronic and grave complication in patients with diabetes, has shown an escalating incidence in China and is currently considered to be the primary cause of end‐stage renal disease. [ 1–3 ] The etiology of DN remains elusive, although it is believed to be related to genetic factors, [ 4,5 ] metabolic abnormalities triggered by hyperglycemia, [ 6–8 ] and hypertension. [ 9–11 ] DN is characterized by distinctive histological changes, including mesangial sclerosis (diffuse or nodular), thickening of glomerular and tubular basement membranes, and exudative lesions.…”
Section: Introductionmentioning
confidence: 99%
“…The repeated oral administration of 50 and 250 mg/kg/day of PUE for 30 days in rats showed no changes in hematological and biochemical parameters (Chung et al, 2009). A single oral administration of 6, 12, or 24 mg/kg of PUE in healthy Korean subjects indicated no clinically significant changes and no serious adverse effects on of vital signs (Kim et al, 2017).…”
Section: Toxicity Of Puerarinmentioning
confidence: 90%